Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers

NCT03270800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Helicobacter Pylori Infected Subjects
Helicobacter Pylori Naive Subjects

Interventions

BIOLOGICAL: CTA control
BIOLOGICAL: IMX101 vaccine

Sponsor

ImevaX